The risk-benefit discussion should include GI intolerance, dehydration/renal risk, gallbladder disease, pancreatitis warning symptoms, diabetic retinopathy monitoring in some patients, hypoglycemia risk when combined with insulin/sulfonylureas, and the thyroid C-cell tumor contraindication context
Epub 2012 May 30
Details reflect materials reviewed in July 2026 - confirm anything time-sensitive before you enroll
Side Effects Gastrointestinal symptoms, specifically nausea, vomiting, diarrhea, and constipation, are far and away the most frequently reported side effects associated with GLP1 receptor agonist use
Retatrutide (Triple Agonist): Mimics the two hormones above plus a third: Glucagon
The mechanism is straightforward: semaglutide slows gastric emptying and reduces stomach acid production, both of which impair dietary B12 absorption over time